Outcome measures for multiple sclerosis clinical trials: relative measurement precision of the Expanded Disability Status Scale and Multiple Sclerosis Functional C omposite
Jeremy Hobart(Peninsula College of Medicine and Dentistry), Alan J. Thompson(Queen Mary University of London), Bernard M.J. Uitdehaag(Amsterdam UMC Location Vrije Universiteit Amsterdam), Frederik Barkhof(Netherlands Institute for Neuroscience), Nynke F. Kalkers(OLVG), Chris H. Polman(Vrije Universiteit Amsterdam)
Cited by 73
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
|Annals of Neurology|2001|7k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k